THERAPEUTIC OPTIONS USED IN THE TREATMENT OF COVID – 19: A LITERARY REVIEW
DOI:
https://doi.org/10.5281/zenodo.4245243Keywords:
Covid, Tratamento, Medicamentos, Plasma Convalescente, Dexametasona, Remdesivir, Prevenção, Sars-Cov-2.Abstract
A new type of coronavirus appeared in the city of Wuhan in China in 2019. SARS-COV-2 is a single-stranded positive sense RNA virus, surrounded by four proteins, called Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N). The new coronavirus has been a challenge for healthcare professionals due to the lack of effective treatment against the disease. The aim of the present study was to seek information about the main therapeutic options currently employed in Covid-19 treatment. Thus, it was possible to identify that several of these drugs for the treatment of SARS-CoV-2 show promising results, but they still lack more information and studies, therefore, there is no safe and effective treatment.
Downloads
References
SANDERS .M, JAMES. Et al. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. Jama. 12 de Maio de 2020. 323(18):1824-1836.
ANANIAS ALVES CRUZ, et al. Considerações sintomáticas e medicamentosa a respeito do no coronavírus: Uma revisão da literatura sobre farmacologia, efeitos adversos, fisiopatogenia e formas de tratamento do COVID-19. Amazonas. 2020.
World Health Organization. Afirma que COVID-19 é agora caracterizada como pandemia. 11 de março de 2020. (Acessado em: 05 de março de 2020) https://www.paho.org/bra/index.php?option=com_content&view=article&id=6120:oms-afirma-que-covid-19-e-agora-caracterizada-como-pandemia&Itemid=812.
WANG, YEMING. ZHANG DINGYU. GUANHUA. RONGH. JIN, YANG. HU, YI. Remdesivir em adultos com COVID-19 grave: um estudo multicêntrico, randomizado, duplo-cego, controlado por placebo. Pequim. 2020
CHEN, LONG. XION, JING. BAO, LEI. SHI, YANG. Plasma convalescente como terapia potencial para COVID-19. 2020.
COLPANI, V. STEIN, C. PAGANO, CGM. GRAF, DD. MATUOKA, JY. MEDEIROS, FC. BRITO, GV. MARRA, LP. PARREIRA, PCL. BAGATINNI, AM. PACHITO, DV. OLIVEIA, Jr HÁ. RIEIRA R. FALAVIGNA M. Corticoides para infecção por SARS-Cov-2 (Covid 19). Revisão sistemática rápida. Disponível em: https://oxfordbrazilebm.com/index.php/2020/05/18/ corticoides-para-infeccao-por-sars-cov-2-covid-19-revisao-sistematica-rapida/. (Acessado em: 06 de março de 2020).
HORBY, PETER. et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. Julho de 2020. Volume 17.
M TOMAZINI, BRUNO. et.al. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. Jama. Setembro de 2020. Volume 1701.
GREIN, JONATHAN. Et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. Junho de 2020. Volume 11;382(24):23.
WANG, YEMING. Et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. Maio de 2020. Volume 16;395(10236):15.
YE, MINGXIANG. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol. Abril de 2020. Volume 15; 10.1002.
CHENGUANG, SHEN. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. Jama. Abril de 2020; 323(16): 1582-1589.
DUAN, KAI. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. Abril de 2020; 117(17): 9490-9496
